131 related articles for article (PubMed ID: 20621376)
1. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes.
Ma Y; Cheng Y; Wang J; Cheng H; Zhou S; Li X
Diabetes Res Clin Pract; 2010 Oct; 90(1):60-5. PubMed ID: 20621376
[TBL] [Abstract][Full Text] [Related]
2. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.
Telejko B; Kuzmicki M; Zonenberg A; Szamatowicz J; Wawrusiewicz-Kurylonek N; Nikolajuk A; Kretowski A; Gorska M
Diabetes Res Clin Pract; 2009 Apr; 84(1):68-75. PubMed ID: 19185944
[TBL] [Abstract][Full Text] [Related]
3. [The expression of visfatin in placenta in women with gestational diabetes mellitus].
Luo JX; Liu XH; Zhang L; He GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):204-7. PubMed ID: 21500554
[TBL] [Abstract][Full Text] [Related]
4. Visfatin expression is elevated in normal human pregnancy.
Morgan SA; Bringolf JB; Seidel ER
Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
[TBL] [Abstract][Full Text] [Related]
5. In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes.
Lappas M; Mitton A; Permezel M
J Endocrinol; 2010 Jan; 204(1):75-84. PubMed ID: 19833719
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between the expression of gastrocolic omentum visfatin mRNA and gestational diabetes mellitus].
Liang Y; Xu XM; Wang HS; Wang PW
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):824-7. PubMed ID: 19087564
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.
Telejko B; Kuzmicki M; Zonenberg A; Modzelewska A; Niedziolko-Bagniuk K; Ponurkiewicz A; Wawrusiewicz-Kurylonek N; Nikolajuk A; Szamatowicz J; Laudanski P; Kretowski A; Gorska M
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):87-92. PubMed ID: 20180161
[TBL] [Abstract][Full Text] [Related]
8. Increased visfatin concentrations in women with gestational diabetes mellitus.
Krzyzanowska K; Krugluger W; Mittermayer F; Rahman R; Haider D; Shnawa N; Schernthaner G
Clin Sci (Lond); 2006 May; 110(5):605-9. PubMed ID: 16489932
[TBL] [Abstract][Full Text] [Related]
9. Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes.
Kuzmicki M; Telejko B; Wawrusiewicz-Kurylonek N; Nikolajuk A; Zwierz-Gugala D; Jelski W; Kolodziejczak M; Zonenberg A; Wilczynski J; Kretowski A; Gorska M; Szamatowicz J
Gynecol Endocrinol; 2011 Dec; 27(12):1065-9. PubMed ID: 21609194
[TBL] [Abstract][Full Text] [Related]
10. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
[TBL] [Abstract][Full Text] [Related]
11. Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus.
Coskun A; Ozkaya M; Kiran G; Kilinc M; Arikan DC
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1014-8. PubMed ID: 20059442
[TBL] [Abstract][Full Text] [Related]
12. Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Cienfuegos JA; Salvador J; Frühbeck G
Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):245-53. PubMed ID: 20106640
[TBL] [Abstract][Full Text] [Related]
13. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies.
Lappas M; Yee K; Permezel M; Rice GE
J Endocrinol; 2005 Sep; 186(3):457-65. PubMed ID: 16135665
[TBL] [Abstract][Full Text] [Related]
14. Visfatin in pregnancy: proposed mechanism of peptide delivery.
Katwa LC; Seidel ER
Amino Acids; 2009 Oct; 37(4):555-8. PubMed ID: 18953631
[TBL] [Abstract][Full Text] [Related]
15. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
[TBL] [Abstract][Full Text] [Related]
16. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
17. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
Chang YC; Chang TJ; Lee WJ; Chuang LM
Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum vaspin levels and vaspin expression in adipose tissue and smooth muscle tissue in pregnant women with and without gestational diabetes.
Tang Y; Qiao P; Qu X; Bao Y; Li Y; Liao Y; Ying H
Clin Endocrinol (Oxf); 2017 Oct; 87(4):344-349. PubMed ID: 28636750
[TBL] [Abstract][Full Text] [Related]
19. Placental effects of systemic tumour necrosis factor-α in an animal model of gestational diabetes mellitus.
Bobadilla RA; van Bree R; Vercruysse L; Pijnenborg R; Verhaeghe J
Placenta; 2010 Dec; 31(12):1057-63. PubMed ID: 20951428
[TBL] [Abstract][Full Text] [Related]
20. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta.
Marseille-Tremblay C; Ethier-Chiasson M; Forest JC; Giguère Y; Masse A; Mounier C; Lafond J
Mol Reprod Dev; 2008 Jun; 75(6):1054-62. PubMed ID: 18095312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
